![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Mehta Api Pvt. Ltd. Boisar In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.
They are recognized for Strategic partner for Innovator & Generic API companies for >50 years.
One of their significant offerings is Bisoprolol fumarate, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2013-342 - Rev 02
This Chemical Type CEP, issued on May 13, 2019, remains in force until November 14, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 1710 associated with this CEP further emphasizes